Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers November 20, 2017
Pharmacy Choice - News - U.S. Pharmaceutical Industry - November 20, 2017

Pharmacy News

 U.S. Pharmaceutical Industry
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

10/21/17 - "Benzazepine Sulfonamide Compounds" in Patent Application Approval Process (USPTO 20170275253)
By a News Reporter-Staff News Editor at Obesity, Fitness& Wellness Week A patent application by the inventors Hoves, Sabine; Koerner, Matthias; Wang, Lisha; Yun, Hongying; Zhu, Wei; Zhang, Weixing, filed on June 14, 2017, was made available online on October 5, 2017, according to news reporting originating from Washington, D.C., by NewsRx corresp
10/21/17 - "Pharmaceutical Composition Containing Ginkgolide B and Blood Platelet Prostaglandin Cyclooxygenase Inhibitor and Method for Preparation Thereof and...
By a News Reporter-Staff News Editor at Obesity, Fitness& Wellness Week A patent application by the inventor SUN, Yi, filed on September 25, 2015, was made available online on October 5, 2017, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application is assigned to Chengdu Baiyu Pharmaceutica
10/21/17 - Activists Slam Ryan Costello's Entanglement in DEA/Pharma Scandal
Today, activists and community leaders held a press conference outside Representative Ryan Costello's office to hold him accountable for cosponsoring a bill that crippled the DEA's ability to stem the flow of prescription narcoticsselling his constituents out for $300,000 in Pharma money at the same fatal overdoses in Pennsylvania were...
10/21/17 - Astrocyte Pharmaceuticals, University of Texas System Assigned Patent for Compounds for Treating Neurological Conditions
Astrocyte Pharmaceuticals, Cambridge, Massachusetts, and the University of Texas System, Austin, Texas, have been assigned a patent developed by three co-inventors for "compounds and methods for treating neurological and cardiovascular conditions." The co-inventors are William S. Korinek, Mystic, Connecticut, James D. Lechleiter, San Antonio, and T
10/21/17 - Big Pharma's opioid gambit
For decades, America has waged an ineffective war on drug pushers and drug lords, from Bronx street corners to Medellin, Colombia, regarding them as among the most contemptible specimens of humanity. Big Pharma should be writhing in embarrassment this week after The Washington Post and 60 Minutes reported that pharmaceutical lobbyists had man
10/21/17 - Brain damage caused by Zika exposure in utero can be detected by both fetal MRI and ultrasound
By a News Reporter-Staff News Editor at Obesity, Fitness& Wellness Week SAN DIEGO Clinicians managing Zika-affected pregnancies should use magnetic resonance imaging in addition to standard ultrasound because the more detailed MRI images can reveal more extensive areas of damage to the developing fetal brain, according to research presented dur
10/21/17 - Carlos Trejo Sosa: We Have Native Doctors in Cuba Like Nigeria
Carlos Trejo Sosa, the Cuban Ambassador to Nigeria tells Stanley Nkwazema about the country s 2018 elections, the first in several years Historic Moments of 1974 Carlos Trejo Sosa, the Cuban Ambassador to Nigeria, was full of praises for THISDAY. He just could not hide it. Your newspaper has paid a lot of attention to Cuba; we are pleased tha
10/21/17 - CorrexHassan-mf-vn-102117
Maggie Hassan, D- N.H., has received $64,383 from the pharmaceutical industry since 2013. An article in Friday s Valley News about a law passed last year that has hampered the Drug Enforcement Agency s ability to stop the diversion of prescription drugs to the black market inaccurately reported the period when those contributions were made.
10/21/17 - Ebola vaccine wins approval from regulators [China Daily: Africa Weekly]
This makes China the third country, after the United States and Russia, with vaccines available for use to combat the deadly infectious disease, the China Food and Drug Administration said. The vaccine improves China's ability to prevent and control major public health threats and provides a new means for China to handle global disease epidemics ef
10/21/17 - IBM Watson Health Head of West Coast Sales Joins Deep 6 AI
PASADENA, CA- 21 Oct, 2017- Former IBM Watson Health sales executive, Bill Hutchins, is joining Deep 6 AI to support the rapid expansion of its clinical trial patient recruitment platform across hospitals, pharmaceutical companies and contract research organizations. Hutchins previously served as IBM Watson for Oncology Sales Director- Western US w
10/21/17 - Lantheus Medical Imaging Assigned Patent for Methods for Making Ultrasound Contrast Agents
Lantheus Medical Imaging, North Billerica, Massachusetts, has been assigned a patent developed by six co-inventors for "methods for making ultrasound contrast agents." The co-inventors are Simon P. Robinson, Stow, Massachusetts, Robert W. Siegler, Chelmsford, Massachusetts, Nhung Tuyet Nguyen, Westford, Massachusetts, David C. Onthank, Groton, Mass
10/21/17 - PTC THERAPEUTICS INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of PTC Therapeutics, Inc. - (PTCT)
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick& Foti, LLC, announces that KSF has commenced an investigation into PTC Therapeutics, Inc.. On February 23, 2016, PTC revealed that it had received a Refuse to File letter from the U.S. FDA on its New Drug Application for its primary drug Transl
10/21/17 - Rep. Krishnamoorthi Joins Colleagues in Demanding Answers on the DEA's Relationship With the Pharmaceutical Industry
Raja Krishnamoorthi, D- Ill., issued the following news release:. Today, Congressman Raja Krishnamoorthi joined Congressmen Mark DeSaulnier, Jim Cooper, Jamie Raskin, and Matt Cartwright in sending a letter to the Acting Director of the Drug Enforcement Administration demanding answers about the agency's failure to disclose its concerns about effor
10/21/17 - Senate Aging Committee Issues Testimony From National Institute of Diabetes
The Senate Special Committee on Aging issued the following testimony by Griffin Rodgers, director of the National Institute of Diabetes and Digestive and Kidney Diseases, at a hearing entitled "Progress Toward a Cure for Type I Diabetes: Research and the Artificial Pancreas":. On behalf of NIDDK and the other Institutes and Centers of the National
10/21/17 - Shingrix Approved in the US for Prevention of Shingles in Adults Aged 50 and Over
GlaxoSmithKline issued the following news release:. GlaxoSmithKline plc today announced that the US Food and Drug Administration has approved Shingrix for the prevention of shingles in adults aged 50 years and older. Thomas Breuer, Senior Vice President and Chief Medical Officer of GSK Vaccines said: "Shingrix represents a significant scientific...
10/21/17 - Solixa Technologies Assigned Patent for Aqueous Drug Delivery System
Solixa Technologies, Scituate, Massachusetts, has been assigned a patent developed by Kyle A. Reed, Manalapan, New Jersey, for an "aqueous drug delivery system." The patent application was filed on March 30, 2015. Written by Kusum Sangma; edited by Sudarshan Harpal.
10/21/17 - Tanner Pharma Group to Attend Upcoming CPHI Worldwide Conference
Top executives from Tanner Pharma Group, a Charlotte- based global pharmaceutical services company, will attend the CPhI Worldwide event on October 24- 26 in Messe Frankfurt, Germany. Tanner Pharma leverages more than 15 years of pharma services experience to provide regulatory compliance and logistical efficiency, all within an EU-GDP compliant
10/21/17 - Vertex Pharmaceuticals Assigned Patent for Method for Measuring ATR Inhibition Mediated Increases in DNA Damage
Vertex Pharmaceuticals, Boston, and the University of Newcastle Upon Tyne, Newcastle Upon Tyne, United Kingdom, have been assigned a patent developed by six co-inventors for a "method for measuring ATR inhibition mediated increases in DNA damage." The co-inventors are Susanna Falcon, Newbury, United Kingdom, Philip Reaper, Shillingford, United King
10/21/17 - White House considering task force on drug pricing
WASHINGTON- President Donald Trump is considering launching a bipartisan task force to investigate the rising cost of prescription drugs, sources with knowledge of the discussion say. The announcement could come as early as next week, but the sources caution that discussions remain in the early stages and are still fluid. The White House declined t
10/20/17 - "A Pharmaceutical Composition for the Treatment of Multi-Drug Resistant Infections" in Patent Application Approval Process (USPTO 20170273939)
By a News Reporter-Staff News Editor at Drug Week A patent application by the inventors VISHWAKARMA, Ram; KUMAR, Ajay; KHAN, Inshad Ali; BHARATE, Sandip Bibishan; JOSHI, Prashant; SINGH, Samsher; SATTI, Naresh, filed on October 21, 2015, was made available online on October 5, 2017, according to news reporting originating from Washington, D.C., b
10/20/17 - "Pharmaceutical Composition for Topical Administration" in Patent Application Approval Process (USPTO 20170273945)
By a News Reporter-Staff News Editor at Drug Week A patent application by the inventors LIU, Wai Leung; PURKINS, Lynn; YEADON, Michael, filed on June 9, 2017, was made available online on October 5, 2017, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application has not been assigned to a com
10/20/17 - 2017 DrugDev Summit, Co-Chaired by Novartis and CSL Behring, to Convene 100+ Clinical Leaders to Improve the Clinical Trial Experience for Patients, Sites and Study Teams [Sport360]
-The worlds most progressive pharmaceutical companies, CROs and sites will continue to advance beyond the clinical trial status quo at the 2017 DrugDev Summit in Philadelphia, November 7-8. Co-chaired by Novartis and CSL Behring, DrugDevs annual Summit is widely regarded by customers as the premier open forum for sharing clinical trial best practic
10/20/17 - Abbott Reports Third Quarter 2017 Results
Excluding specified items, adjusted diluted EPS from continuing operations was $0.66 in the third quarter, at the high end of the previous guidance range of $0.64 to $0.66. In September, Abbott received U.S. FDA approval for its FreeStyle Libre glucose monitoring system as a replacement1 for finger stick blood glucose monitoring. During the quarter
10/20/17 - AcelRx's DSUVIA? Clinical Trial Results Selected as a "Top Abstract" for Oral Presentation at ASA's Annual Meeting - ANESTHESIOLOGY 2017
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical, today announced its clinical data presentation on the safety and efficacy of DSUVIA?, 30 mcg classified by age group across four clinical trials at the American Society of Anesthesiologists' ANESTHESIOLOGY 2017 Annual Meeting. The information presented during the session was authored
10/20/17 - Adverse events spike after blood pressure meds go generic in Canada
By a News Reporter-Staff News Editor at Drug Week DALLAS, One month after generic versions of three widely-used blood pressure drugs became available in Canada, hospital visits for adverse events spiked in generic drug users, according to new research in Circulation: Cardiovascular Quality and Outcomes, an American Heart Association journal.
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415